Ganciclovir: a review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections

D Faulds, RC Heel - Drugs, 1990 - Springer
Synopsis Ganciclovir is a nucleoside analogue with antiviral activity in vitro against
members of the herpes group and some other DNA viruses. It has demonstrated efficacy …

Ganciclovir: an update of its therapeutic use in cytomegalovirus infection

A Markham, D Faulds - Drugs, 1994 - Springer
Synopsis The antiviral nucleoside analogue ganciclovir has demonstrated in vitro activity
against human cytomegalovirus and effectively treats infection caused by this organism in …

Human pharmacokinetics and tolerance of oral ganciclovir

MA Jacobson, P de Miranda… - Antimicrobial agents …, 1987 - Am Soc Microbiol
Ganciclovir is a nucleoside analog which inhibits the replication of herpesviruses in vitro and
which has been effective by intravenous administration for the treatment of severe …

Antiviral activity and mechanism of action of ganciclovir

T Matthews, R Boehme - Reviews of infectious diseases, 1988 - academic.oup.com
Abstract Ganciclovir (9-[(1, 3-dihydroxy-2-propoxy) methyl] guanine) is a potent inhibitor of
viruses of the herpes family, including cytomegalovirus (CMV), that are pathogenic for …

Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus

OL Laskin, DM Cederberg, J Mills, LJ Eron… - The American journal of …, 1987 - Elsevier
Ganciclovir is a congener of acyclovir with in vitro activity against cytomegalovirus. Ninety-
seven patients with the acquired immune deficiency syndrome (AIDS) and a serious …

Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients

JK McGavin, KL Goa - Drugs, 2001 - Springer
Ganciclovir is a nucleoside guanosine analogue which incorporates ganciclovir
triphosphate (the active moiety) into DNA during elongation, thereby inhibiting viral …

Ganciclovir treatment of life-or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients

WC Buhles Jr, RJ Mastre, AJ Tinker… - Reviews of infectious …, 1988 - academic.oup.com
A total of 314 immunocompromised patients with serious cytomegalovirus (CMV) infection
treated with ganciclovir administered intravenously were studied. Rates of favorable clinical …

Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function

JP Sommadossi, R Bevan, T Ling, F Lee… - Reviews of Infectious …, 1988 - academic.oup.com
The pharmacokinetics of ganciclovir was evaluated in 21 patients with life-or sight-
threatening cytomegalovirus infections. Thirteen patients had normal renal function and …

Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro

JF Manischewitz, GV Quinnan Jr… - Antimicrobial agents …, 1990 - Am Soc Microbiol
Ganciclovir and foscarnet possess substantial activity against cytomegalovirus. Both exhibit
dose-limiting toxicity, which reduces their clinical usefulness. We demonstrated synergistic …

Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts

A Erice, MC Jordan, BA Chace, C Fletcher… - Jama, 1987 - jamanetwork.com
Thirty-one immunocompromised patients with severe cytomegalovirus (CMV) disease were
treated with intravenous ganciclovir. Twenty-one patients had received transplants—15 …